Form 4 for BSX Boston Scientific
Accepted 2023-09-01 00:00:00 ET · period of report 2023-08-30 · accession 0001225208-23-008626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-09-01 | 2023-08-30+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +142.5K | 175.2K | +437% | $0 |
| 2023-09-01 | 2023-08-30 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -318.2K | 1.50M | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-31 | G | A | 1,095 | $0.00 | 176,245 | I | — | — | |
| 2 | Common | Common Stock | 2023-08-30 | G | A | 141,450 | $0.00 | 175,150 | I By Trust | — | — | (F4) Balance includes 33,700 shares that were previously reported as directly beneficially owned by the reporting person. Such shares are held indirectly in a trust, of which the reporting person and his spouse are trustees and beneficiaries. |
| 3 | Common | Common Stock | 2023-08-30 | G | D | 318,218 | $0.00 | 1,498,922 | D By Trust | — | — | (F2) Balance reflects the decrease of 33,700 shares that were previously reported as directly beneficially owned by the reporting person. Such shares are held indirectly in a trust, of which the reporting person and his spouse are trustees and beneficiaries. |